EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
WO2006007448A2
(en)
|
2004-06-17 |
2006-01-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions and related methods of use
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
DK1907424T3
(en)
|
2005-07-01 |
2015-11-09 |
Squibb & Sons Llc |
HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED death ligand 1 (PD-L1)
|
ES2437327T3
(es)
|
2007-06-18 |
2014-01-10 |
Merck Sharp & Dohme B.V. |
Anticuerpos para el receptor PD-1 humano de muerte programada
|
BR112015013440B1
(pt)
|
2012-12-13 |
2020-12-08 |
Aduro Biotech, Inc |
composições compreendendo dinucleotídeos de purina cíclicos com estereoquímicas
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
WO2014189806A1
(en)
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
JP6453855B2
(ja)
|
2013-05-18 |
2019-01-16 |
アドゥロ バイオテック,インク. |
「インターフェロン遺伝子の刺激因子」依存性シグナル伝達を活性化するための組成物及び方法
|
US9872852B2
(en)
|
2013-09-04 |
2018-01-23 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
EA029856B9
(ru)
|
2014-06-04 |
2018-08-31 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Циклические динуклеотиды в качестве модуляторов стимулятора генов интерферона (sting)
|
JP6405457B2
(ja)
|
2014-09-11 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
Pd−1/pd−l1およびcd80(b7−1)/pd−l1タンパク質/タンパク質相互作用の大環状阻害剤
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
DK3233882T3
(da)
|
2014-12-16 |
2020-01-27 |
Kayla Therapeutics |
Fluorinerede cykliske dinukleotider til cytokininduktion
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
AR103894A1
(es)
|
2015-03-10 |
2017-06-14 |
Aduro Biotech Inc |
Composiciones y métodos para activar la señalización dependiente del estimulador del gen interferón
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2016164619A2
(en)
|
2015-04-07 |
2016-10-13 |
Spring Bank Pharmaceuticals, Inc. |
Compositions and methods for the treatment of hbv infection
|
TW201717968A
(zh)
|
2015-07-14 |
2017-06-01 |
春季銀行製藥公司 |
誘導rig-i和其他模式辨識受體之化合物及組成物
|
WO2017019896A1
(en)
*
|
2015-07-29 |
2017-02-02 |
Novartis Ag |
Combination therapies comprising antibody molecules to pd-1
|
CR20180101A
(es)
|
2015-08-13 |
2018-04-12 |
Merck Sharp & Dohme |
Compuestos di-nucleóticos cíclicos como agonistas de sting
|
US9809597B2
(en)
|
2015-08-20 |
2017-11-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ganciclovir derivatives for modulating innate and adaptive immunity and for use in immunotherapy
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
BR112018008339A2
(pt)
|
2015-10-28 |
2018-10-30 |
Aduro Biotech Inc |
composições e métodos para ativar estimulador de sinalização dependente do gene de interferon
|
TWI763641B
(zh)
|
2015-11-19 |
2022-05-11 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
US20170146519A1
(en)
|
2015-11-20 |
2017-05-25 |
Oregon Health & Science University |
Sting agonists and methods of selecting sting agonists
|
RU2020113165A
(ru)
|
2015-12-03 |
2020-06-09 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Циклические пуриновые динуклеотиды в качестве модуляторов sting
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
MA55194A
(fr)
|
2015-12-22 |
2022-05-04 |
Incyte Corp |
Composés hétérocycliques en tant qu'immunomodulateurs
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
WO2017123657A1
(en)
|
2016-01-11 |
2017-07-20 |
Gary Glick |
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
|
CN109451740B
(zh)
|
2016-01-11 |
2022-09-02 |
先天肿瘤免疫公司 |
用于治疗与sting活性相关的病症诸如癌症的环状二核苷酸
|
US10143746B2
(en)
|
2016-03-04 |
2018-12-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
DK3429596T3
(da)
|
2016-03-18 |
2022-10-24 |
Immune Sensor Llc |
Cykliske dinukleotide forbindelser og brugs metoder
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
SG11201808708RA
(en)
|
2016-04-07 |
2018-11-29 |
Glaxosmithkline Ip Dev Ltd |
Heterocyclic amides useful as protein modulators
|
WO2017175147A1
(en)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property Development Limited |
Heterocyclic amides useful as protein modulators
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10882833B2
(en)
|
2016-05-23 |
2021-01-05 |
Institute Of Materia Medica, Chinese Academy Of Medical Sciences |
Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
|
MA45116A
(fr)
|
2016-05-26 |
2021-06-02 |
Incyte Corp |
Composés hétérocycliques comme immunomodulateurs
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
SG11201811709WA
(en)
|
2016-07-06 |
2019-01-30 |
Sperovie Biosciences Inc |
Compounds, compositions, and methods for the treatment of disease
|
CR20190071A
(es)
|
2016-07-15 |
2019-10-29 |
Sperovie Biosciences Inc |
Compuestos, composiciones y métodos para el tratamiento de enfermedades
|
WO2018013887A1
(en)
|
2016-07-15 |
2018-01-18 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
US10300145B2
(en)
|
2016-07-15 |
2019-05-28 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
BR112019004042A2
(pt)
*
|
2016-08-30 |
2019-05-28 |
Dana Farber Cancer Inst Inc |
composições de liberação de fármaco e usos das mesmas
|
US20190345191A1
(en)
|
2016-08-31 |
2019-11-14 |
Innate Tumor Immunity, Inc. |
Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
JOP20190070B1
(ar)
|
2016-10-04 |
2023-09-17 |
Merck Sharp And Dohme Llc |
مركبات بنزو[b] ثيوفين كناهضات محفزة لبروتين جينات الإنترفيرون
|
WO2018065360A1
(de)
|
2016-10-07 |
2018-04-12 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
US20200113924A1
(en)
|
2016-12-20 |
2020-04-16 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
ES2891326T3
(es)
|
2017-01-27 |
2022-01-27 |
Janssen Biotech Inc |
Dinucleótidos cíclicos como agonistas de la STING
|
AU2018212788A1
(en)
|
2017-01-27 |
2019-07-25 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as STING agonists
|
US20200055883A1
(en)
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
US10933078B2
(en)
|
2017-02-21 |
2021-03-02 |
Board Of Regents, The University Of Texas System |
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
|
JOP20190218A1
(ar)
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
مركبات ثنائية النيوكليوتيدات حلقية معدلة
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
AR113224A1
(es)
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
EP3621624B1
(en)
|
2017-05-12 |
2023-08-30 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
WO2018234805A1
(en)
|
2017-06-22 |
2018-12-27 |
Curadev Pharma Limited |
SMALL MOLECULAR MODULATORS OF HUMAN STING
|
MX2019015468A
(es)
|
2017-06-22 |
2020-08-03 |
Curadev Pharma Ltd |
Moduladores de moleculas pequeñas de sting humana.
|
JP2020524718A
(ja)
|
2017-06-22 |
2020-08-20 |
キュラデブ・ファーマ・リミテッドCuradev Pharma Limited |
ヒトstingの複素環式小分子調節因子
|
CN110997691B
(zh)
|
2017-07-28 |
2023-11-07 |
百时美施贵宝公司 |
作为抗癌剂的环二核苷酸
|
EP3661499A4
(en)
|
2017-08-04 |
2021-04-21 |
Merck Sharp & Dohme Corp. |
COMBINATIONS OF PD-1 ANTAGONISTS AND BENZO [B]
|
JP2020530838A
(ja)
|
2017-08-04 |
2020-10-29 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
がん治療のためのベンゾ[b]チオフェンSTINGアゴニスト
|
WO2019043634A2
(en)
|
2017-08-30 |
2019-03-07 |
Beijing Xuanyi Pharmasciences Co., Ltd. |
CYCLIC DI-NUCLEOTIDES AS STIMULATORS OF INTERFERON GENE MODULATORS
|
JP7270608B2
(ja)
|
2017-08-31 |
2023-05-10 |
エフ-スター・セラピューティクス・インコーポレイテッド |
化合物、組成物、及び疾患の治療方法
|
WO2019046496A1
(en)
|
2017-08-31 |
2019-03-07 |
Bristol-Myers Squibb Company |
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS
|
ES2945140T3
(es)
|
2017-08-31 |
2023-06-28 |
Bristol Myers Squibb Co |
Dinucleótidos cíclicos como agentes anticancerosos
|
CN111051328B
(zh)
|
2017-08-31 |
2023-11-03 |
百时美施贵宝公司 |
作为抗癌剂的环二核苷酸
|
US11707531B2
(en)
|
2017-09-11 |
2023-07-25 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
US11584774B2
(en)
|
2017-09-11 |
2023-02-21 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
BR112020006761A2
(pt)
|
2017-10-05 |
2020-10-06 |
Glaxosmithkline Intellectual Property Development Limited |
métodos para administrar agonistas de sting
|
WO2019069270A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
GENERATOR STIMULATOR MODULATORS (STING) INTERFERON
|
WO2019069269A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
INTERFERON GENE STIMULATOR MODULATORS USEFUL IN THE TREATMENT OF HIV
|
US11660311B2
(en)
|
2017-10-10 |
2023-05-30 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
BR112020009126A2
(pt)
|
2017-11-10 |
2020-10-20 |
Takeda Pharmaceutical Company Limited |
compostos do modulador sting e métodos de fabricação e uso
|
CN111630036A
(zh)
|
2017-11-20 |
2020-09-04 |
西利康斯瓦特股份有限公司 |
氧代吖啶基乙酸衍生物及其使用方法
|
CA3085337A1
(en)
|
2017-12-15 |
2019-06-20 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as sting agonists
|
US20190185509A1
(en)
|
2017-12-20 |
2019-06-20 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'2' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
AU2018392213B2
(en)
|
2017-12-20 |
2021-03-04 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
|
WO2019122202A1
(en)
|
2017-12-20 |
2019-06-27 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Sting inhibitors
|
US11685761B2
(en)
|
2017-12-20 |
2023-06-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
AU2018392212B9
(en)
|
2017-12-20 |
2021-03-18 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
|
EP3505188A1
(en)
|
2017-12-29 |
2019-07-03 |
Invivogen |
Pro-cyclic dinucleotide conjugates for cytokine induction
|
CN110016025B
(zh)
|
2018-01-08 |
2021-08-06 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
CN110016021B
(zh)
|
2018-01-08 |
2021-05-07 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
US10519187B2
(en)
|
2018-02-13 |
2019-12-31 |
Bristol-Myers Squibb Company |
Cyclic dinucleotides as anticancer agents
|
WO2019161171A1
(en)
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
CA3090746A1
(en)
|
2018-02-16 |
2019-08-22 |
UCB Biopharma SRL |
Pharmaceutical 6,5 heterobicyclic ring derivatives
|
JP7104999B2
(ja)
|
2018-02-21 |
2022-07-22 |
ザ スクリプス リサーチ インスティテュート |
インターフェロン遺伝子刺激因子stingのアゴニスト
|
JP7250808B2
(ja)
|
2018-03-08 |
2023-04-03 |
ブリストル-マイヤーズ スクイブ カンパニー |
抗がん剤としての環状ジヌクレオチド
|
WO2019170912A1
(en)
|
2018-03-09 |
2019-09-12 |
Lidds Ab |
Bioresorbable controlled-release compositions with sting modulating molecules
|
TWI741268B
(zh)
|
2018-03-15 |
2021-10-01 |
美商輝瑞股份有限公司 |
干擾素基因刺激劑(sting)的環戊烷為主體之調節劑
|
EP4242212A3
(en)
|
2018-03-23 |
2023-11-15 |
Takeda Pharmaceutical Company Limited |
Sting modulator compounds with sulfamate linkages, and methods of making and using
|
CA3093849A1
(en)
|
2018-03-23 |
2019-09-26 |
Codiak Biosciences, Inc. |
Extracellular vesicles comprising sting-agonist
|
WO2019185477A1
(en)
|
2018-03-27 |
2019-10-03 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds containing 2-aza-hypoxanthine or 6h-pytazolo[1,5-d][1,2,4]triazin-7-one as sting agonists
|
WO2019185476A1
(en)
|
2018-03-27 |
2019-10-03 |
Boehringer Ingelheim International Gmbh |
Modified cyclic dinucleotide compounds
|
EP3774765A4
(en)
|
2018-04-03 |
2021-12-29 |
Merck Sharp & Dohme Corp. |
Aza-benzothiophene compounds as sting agonists
|
MA52189A
(fr)
|
2018-04-03 |
2021-02-17 |
Merck Sharp & Dohme |
Benzothiophènes et composés associés utilisés en tant qu'agonistes de sting
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
JP7296398B2
(ja)
|
2018-04-06 |
2023-06-22 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
3’3’-環状ジヌクレオチド
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2,2,─環二核苷酸
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
JP2021525706A
(ja)
|
2018-05-25 |
2021-09-27 |
インサイト・コーポレイションIncyte Corporation |
Sting活性化剤としての三環式複素環式化合物
|
BR112020024605A2
(pt)
|
2018-06-01 |
2021-04-06 |
Eisai R&D Management Co., Ltd. |
Métodos para o tratamento de câncer de bexiga
|
EP3807264A1
(en)
|
2018-06-12 |
2021-04-21 |
Ryvu Therapeutics S.A. |
Modulators of stimulator of interferon genes (sting)
|
WO2019243825A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Small molecule modulators of human sting, conjugates and therapeutic applications
|
WO2019243823A1
(en)
|
2018-06-21 |
2019-12-26 |
Curadev Pharma Limited |
Azaheterocyclic small molecule modulators of human sting
|
JP2021530442A
(ja)
|
2018-06-28 |
2021-11-11 |
ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co., Ltd. |
縮合三環系複素環化合物およびその治療上の使用
|
EP3817820A1
(en)
|
2018-07-03 |
2021-05-12 |
IFM Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
US20210236466A1
(en)
|
2018-07-03 |
2021-08-05 |
Ifm Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
JP7440504B2
(ja)
|
2018-07-10 |
2024-02-28 |
エフ-スター・セラピューティクス・インコーポレイテッド |
疾患を治療するための化合物、組成物及び方法
|
WO2020010451A1
(en)
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
TW202030199A
(zh)
|
2018-07-17 |
2020-08-16 |
美商健生生物科技公司 |
作為sting促效劑之環狀二核苷酸
|
WO2020028565A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Tricyclic heteraryl compounds as sting activators
|
WO2020028566A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
CN111386275B
(zh)
|
2018-08-24 |
2023-03-10 |
杭州阿诺生物医药科技有限公司 |
高活性sting蛋白激动剂
|
CN112661773B
(zh)
|
2018-08-29 |
2022-03-11 |
杭州阿诺生物医药科技有限公司 |
Sting蛋白激动剂偶联化合物
|
MX2021002107A
(es)
|
2018-09-06 |
2021-04-28 |
Daiichi Sankyo Co Ltd |
Derivado de dinucleotido ciclico novedoso y conjugado de anticuerpo-farmaco del mismo.
|
CA3113425A1
(en)
|
2018-09-21 |
2020-03-26 |
Shanghai De Novo Pharmatech Co., Ltd. |
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application
|
WO2020072492A1
(en)
|
2018-10-02 |
2020-04-09 |
Baruch S. Blumberg Institute |
Benzamide derivatives as cgas-sting pathway agonists
|
WO2020074004A1
(zh)
|
2018-10-12 |
2020-04-16 |
上海济煜医药科技有限公司 |
环二核苷酸类化合物及其应用
|
AU2019371206A1
(en)
|
2018-10-29 |
2021-05-27 |
Venenum Biodesign, LLC |
Novel sting agonists
|
JP2022507697A
(ja)
|
2018-11-19 |
2022-01-18 |
アイエフエム デュー インコーポレイテッド |
Sting活性に関連する状態を治療するための化合物および組成物
|
JP7469308B2
(ja)
|
2018-12-06 |
2024-04-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
新規の医薬製剤
|
WO2020117623A1
(en)
|
2018-12-07 |
2020-06-11 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
US20220033435A1
(en)
|
2018-12-07 |
2022-02-03 |
Merck Sharp & Dohme Corp. |
Cyclic Di-Nucleotide Compounds as STING Agonists
|
US20220033431A1
(en)
|
2018-12-07 |
2022-02-03 |
Merck Sharp & Dohme Corp. |
Cyclic Di-Nucleotide Compounds as STING Agonists
|
JP2022511540A
(ja)
|
2018-12-14 |
2022-01-31 |
ジエンス ヘンルイ メデイシンカンパニー リミテッド |
Stingアゴニストとしての三環式化合物、ならびにその調製方法および医薬用途
|
CN111655712B
(zh)
|
2018-12-29 |
2021-02-05 |
上海济煜医药科技有限公司 |
作为肿瘤免疫类的化合物及其应用
|
WO2020146237A1
(en)
|
2019-01-07 |
2020-07-16 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
WO2020151682A1
(zh)
|
2019-01-23 |
2020-07-30 |
成都先导药物开发股份有限公司 |
一种大环类免疫调节剂
|
AU2020214477B2
(en)
|
2019-01-31 |
2022-10-27 |
Hitgen Inc. |
Immunomodulator
|
US20230357306A1
(en)
|
2019-02-05 |
2023-11-09 |
Bristol-Myers Squibb Company |
Synthesis of 1,2,5-tri-o-benzoyl-3-dibenzylamino-3-deoxyribose as intermediate for producing 3'-amino-3'-deoxyadenosine and 3'-amino-3'-deoxyguanosine and the protected derivatives thereof
|
DK3934757T3
(da)
|
2019-03-07 |
2023-04-17 |
Inst Of Organic Chemistry And Biochemistry Ascr V V I |
2'3'-cykliske dinukleotider og prodrugs deraf
|
US20220143061A1
(en)
|
2019-03-07 |
2022-05-12 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
WO2020194160A1
(en)
|
2019-03-28 |
2020-10-01 |
Lupin Limited |
Macrocyclic compounds as sting agonists
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
EP3964504A4
(en)
|
2019-04-30 |
2022-12-28 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
AMINOPYRIMIDINE COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
CN114127082A
(zh)
|
2019-05-09 |
2022-03-01 |
阿里戈斯治疗公司 |
作为sting调节剂的经修饰的环状二核苷化合物
|
EP3969452A1
(en)
|
2019-05-16 |
2022-03-23 |
Stingthera, Inc. |
Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use
|
JP2022533390A
(ja)
|
2019-05-16 |
2022-07-22 |
スティングセラ インコーポレイテッド |
オキソアクリジニル酢酸誘導体および使用方法
|
WO2020236586A1
(en)
|
2019-05-17 |
2020-11-26 |
Ifm Due, Inc. |
N-hetaryl-squaramide compounds for treating conditions associated with sting activity
|
EP3976584A1
(en)
|
2019-05-29 |
2022-04-06 |
IFM Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
EP3983078B1
(en)
|
2019-06-12 |
2023-11-15 |
Ryvu Therapeutics S.A. |
Next-generation modulators of stimulator of interferon genes (sting)
|
MA56193A
(fr)
|
2019-06-14 |
2022-04-20 |
Ifm Due Inc |
Composés et compositions pour traiter des états associés à une activité de sting
|
WO2021000770A1
(zh)
|
2019-07-02 |
2021-01-07 |
凯复制药有限公司 |
可增强免疫活性的杂环化合物、其制备方法及其在医药上的应用
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
PE20220937A1
(es)
|
2019-07-22 |
2022-05-31 |
Lupin Ltd |
Compuestos macrociclicos como agonistas de sting y metodos y usos de los mismos
|
TW202114710A
(zh)
|
2019-07-25 |
2021-04-16 |
英屬開曼群島商百濟神州有限公司 |
作為sting促效劑之環狀二核苷酸
|
US20220267364A1
(en)
|
2019-07-25 |
2022-08-25 |
Shanghai Jemincare Pharmaceuticals Co., Ltd. |
Heterocyclic amide compound, preparation method therefor and use thereof
|
AU2020324388A1
(en)
|
2019-08-02 |
2022-02-24 |
Mersana Therapeutics, Inc. |
Bis-[N-((5-carbamoyl)-1H-benzo[d]imidazol-2-yl)-pyrazol-5-carboxamide] derivatives and related compounds as STING (Stimulator of Interferon Genes) agonists for the treatment of cancer
|
AU2020333990A1
(en)
|
2019-08-21 |
2022-04-07 |
The Scripps Research Institute |
Bicyclic agonists of stimulator of interferon genes sting
|
KR20220066277A
(ko)
|
2019-08-21 |
2022-05-24 |
더 스크립스 리서치 인스티튜트 |
인터페론 유전자의 자극인자 sting의 모노시클릭 효능제
|
CN112442033A
(zh)
|
2019-08-28 |
2021-03-05 |
迈德欣国际有限公司 |
Sting通路调节剂及其用途
|
EP4021449A4
(en)
|
2019-08-30 |
2023-11-01 |
University of South Florida |
STITCH MODULATORS, COMPOSITIONS AND METHODS OF USE
|